Flank Pain Completed Phase 2 Trials for Mirabegron (DB08893)

Also known as: Pains, Flank / Pain flank

IndicationStatusPhase
DBCOND0003824 (Flank Pain)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02744430Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent PainTreatment